The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Filter
Locations
Result types
Type of company
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Lock keywords
Exclude keywords
Optional keywords
London, United Kingdom
11-50 Employees
2019
At Akrivia, our vision is to help bring solutions to market that drive cancer treatment strategies from the current one-size-fits-all approach to the precision medicine approach in its truest sense. Cancer is a genetically heterogeneous disease, with a large number of genetic alterations present within a patient’s cancerous growth (typically, a single tumour contains anywhere from tens to millions of genomic aberrations). Founded by Amit Gupta, PhD, Akrivia is at heart an innovation maker with a focus on precision medicine in cancer treatment. Our founder has deep expertise in the field of translational cancer science and has been the lead in several significant research projects at multiple research institutes of repute, the Institute of Cancer Research, London, among them. We aim to be a force in tailored therapeutics where we are able to say more clearly to patients, payers, and providers – ‘this drug is not for everyone, but it is for you'. This is to be done based on a novel and innovative methodology developed by Akrvia’s founder, reflecting the intrinsic biology of the disease. Our innovative proprietary molecular sub-typing systems provide precise details on specific disease biology by considering each patient tumour's unique genomic and immune makeup. Our ultimate goal is to develop these innovative, ground-breaking classifier systems for clinical practice.
+
Featured
Providing Precision Medicine Solutions for Cancer through Biology-Guided Diagnostics
... PROVIDING PRECISION MEDICINE SOLUTIONS IN CANCER THROUGH BIOLOGY GUIDED DIAGNOSTICS. ...
Fort Worth, United States
1-10 Employees
2016
D., one of the world’s leading experts in blood-based biomarkers for Alzheimer’s disease and other neurodegenerative diseases. O’Bryant is the founder of the company and Professor of Pharmacology and Neuroscience at UNTHSC. The revolutionary NeuroFirstTM Memory test from Cx Precision Medicine is a simple blood test for people who are 60 and up that can help primary care physicians rule out dementia and differentiate between those patients who would benefit from further neurological testing and those whose symptoms are very unlikely to be caused by Alzheimer’s Dementia, resulting in peace of mind and better outcomes at lower costs.
+
Featured
Evidence-based Precision Medicine
... Cx Precision Medicine | ...
Tiruchirappalli, India
1-10 Employees
2021
Genix.ai is a machine learning assisted clinical investigation service using next generation sequencing(NGS) and biomedical imaging data. We are providing personalized treatment strategies for clinicians with timely detection of biomarkers to fight rare diseases in infants, extend and improve quality of life with cancer patients and cost effective detection of complex infections. Genix.ai as a platform aims to bridge the gap between traditional diagnostic methods and effective personalized medicine. Our services include three major categories namely sequencing, analysis and data solutions for clinical research. AI technology is perfect for best business solutions & we offer help to achieve your goals. Tell us about your product and we will give you expert assistance. Having a home based business is a wonderful asset to your life. More sequencing data in size than any other service provider in the industry.
+
Featured
Genomic Precision Medicine with genix.ai
... Genomic Precision Medicine with genix. ...
San Francisco, United States
11-50 Employees
2015
We are a team of data scientists, engineers, clinicians, researchers and therapists, fully committed to develop novel digital biomarkers and bring digital health solutions to market as standalone programs or alongside medications. We provide real-time interventions supporting each patient at their point of need. Precision DTx delivers superior improvement in outcomes in depression and/or anxiety.
+
Featured
Digital Precision Medicine for Mental Health
... Feel Therapeutics is a Digital Precision Medicine company bringing objective data and passive measurement into the field of Mental Healthcare. ...
+
Featured
Precision medicine through polymathic AI
... CoSyne Therapeutics is a vertically integrated AI drug discovery company aiming to bring speed to precision medicine through polymathic AI to help patients with under-served diseases of the brain. ...
Rotterdam, Netherlands
11-50 Employees
2018
A clinical trial is a research study where Clinicians test new medicine and treatments to ensure their effectiveness and safety.
+
Featured
Dive Into the New Age of Precision Medicine through Data Ownership & Anonymized Sharing
... Dive Into the New Age of Precision Medicine through Data Ownership & Anonymized ...
+
Featured
Curii | Our mission is to accelerate biomedical research and precision medicine through open standards, open data, and free and open source software.
... Curii | Our mission is to accelerate biomedical research and precision medicine through open standards, open data, and free and open source software. ...
Portland, United States
1-10 Employees
2017
We are now applying these insights across a variety of related diseases with diligence and precision. We are investigating several therapeutic strategies for modulating the palmitoylome. At Circumvent, we are focused initially on CLN1 Batten Disease, which is one of the most common and most severe forms of Batten Disease. In the next 20 years, neurodegenerative disease is expected to overtake cancer as the second leading cause of death worldwide. Circumvent was formed with the mission of developing precision medicines for neurodegenerative disease, starting with Batten Disease. We built an experienced team of scientists and clinicians to focus on diseases with high-fidelity, predictive animal models, a clear clinical development path, and the potential to reach the market quickly. Batten disease is a group of rare neurodegenerative diseases that typically present during childhood and progress rapidly.
+
Featured
Developing precision medicines for neurodegenerative disease
... Developing precision medicines for neurodegenerative ...
Bethesda, United States
501-1000 Employees
2012
Advancing cell and gene therapies to accelerate time to approval and deliver commercial success. Delivering high-yield insights that unlock the full potential of data to power clinical development and commercial success.
+
Featured
Precision Medicine Group
... With the discipline of precision medicine as our foundation, Precision Medicine Group leverages specialized expertise to move science closer to health. ...
Rome, Italy
1-10 Employees
2016
Realizza progetti e soluzioni che garantiscono l’utilizzo ottimale delle risorse mediche della struttura organizzativa e delle tecnologie a disposizione. Si avvale di professionisti medici altamente qualificati, con inclinazione a spostarsi su tutto il territorio nazionale e all’estero. Precision Medicine realizza progetti innovativi di gestione diretta piuttosto che di coordinamento e organizzazione in outsourcing di servizi medico sanitari affidategli da interlocutori pubblici (d.lgs 502/92), privati accreditati e privati puri. Le opportunità e i vantaggi derivanti dall’esternalizzazione di processi aziendali possono rappresentare un enorme valore aggiunto in termini di efficienza ed efficacia di risultati raggiunti, anche in fattori core per le aziende sanitarie. In un momento in cui i nuovi manager della sanità devono capire che le inefficienze del sistema stanno consumando gran parte delle risorse disponibili, dove è tangibile che le risorse disponibili sono “scarse” e non ci si può più permettere inefficienze del sistema, probabilmente bisogna mettere in atto sistemi di outsourcing di fattori chiave di produzione, valorizzando la gestione di processi core e non solo esternalizzando “funzioni verticali”.
+
Featured
Precision Medicine
... Precision Medicine ha un database di medici specialisti radiologi e appartenenti ad altre branche specialistiche, selezionati in base alle competenze professionali, all’esperienza maturata, alle caratteristiche di serietà e affidabilità, tutti con naturale inclinazione a spostarsi in Italia ...
Technologies which have been searched by others and may be interesting for you:
Some interesting numbers and facts about the results you have just received for Precision Medicine
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 396 |
| Amount of suitable service providers | 309 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2012 |
| Youngest suiting company | 2021 |
Precision medicine is a medical model that proposes the customization of healthcare, with medical decisions, practices, treatments, and products being tailored to the individual patient. This approach relies heavily on the understanding that each person’s genetic makeup, environment, and lifestyle can influence the efficacy of therapeutic interventions, disease prevention strategies, and diagnoses. Central to precision medicine is the use of genomic and molecular data to classify patients into subpopulations that differ in their susceptibility to a particular disease or their response to a specific treatment. Preventative or therapeutic interventions can then be concentrated on those who will benefit, sparing expense and side effects for those who will not. The role of precision medicine is transformative within the healthcare sector, offering the potential for significantly more personalized, predictive, and preventative care. By integrating detailed biologic, genetic, and phenotypic data with clinical insights, precision medicine enables a deeper understanding of disease mechanisms and the development of targeted treatments. This approach has already made significant impacts in areas such as oncology, where tailored therapies based on the genetic profiles of both the patient and the tumor can lead to dramatically improved outcomes. The overarching impact of precision medicine is the shift from a "one-size-fits-all" approach to a more dynamic, personalized healthcare paradigm, promising greater efficiency and effectiveness in treatment protocols and a substantial reduction in healthcare costs.
1. Personalized Treatment Plans
Precision medicine allows for the creation of highly personalized treatment plans based on an individual's genetic makeup. This approach significantly increases the effectiveness of treatments by targeting specific aspects of an individual's health, leading to better outcomes and fewer side effects compared to traditional one-size-fits-all methods.
2. Early Disease Detection
By focusing on the genetic predispositions a person may have towards certain diseases, precision medicine facilitates earlier detection of health conditions. Early detection often means that treatment can be started sooner, which is crucial in managing and potentially curing many diseases.
3. Cost-Effectiveness
Although the initial costs of genetic testing and personalized medicine can be high, precision medicine can ultimately lead to cost savings for the healthcare system. By avoiding the trial-and-error approach of standard treatments and reducing the likelihood of adverse reactions, resources are used more efficiently, leading to a decrease in unnecessary healthcare spending.
4. Enhanced Drug Development
Precision medicine accelerates the development of new drugs by identifying the genetic factors that influence how individuals respond to specific medications. This knowledge helps pharmaceutical companies create more effective drugs with fewer side effects, benefiting a wider range of patients.
While evaluating the different suppliers make sure to check the following criteria:
1. Compliance with Regulatory Standards
Ensure the supplier adheres to all relevant local and international regulations, including data protection laws critical for patient confidentiality in precision medicine.
2. Technological Capabilities
Assess the supplier's ability to provide cutting-edge technologies, such as next-generation sequencing and AI-driven data analytics, which are fundamental for precision medicine.
3. Experience and Expertise
Look for suppliers with a proven track record in precision medicine, including successful case studies or partnerships in the field.
4. Customization Flexibility
The supplier should offer customizable solutions that can be tailored to specific research needs or patient care strategies in precision medicine.
5. Scalability
Consider whether the supplier's solutions can scale up to meet growing demands, a crucial factor for long-term collaboration in the rapidly evolving field of precision medicine.
6. Support and Training Services
Check if the supplier provides comprehensive support and training for their products and services, ensuring smooth integration and utilization in precision medicine programs.
Precision medicine's application in the pharmaceutical industry is transformative, enabling companies to develop drugs tailored to specific genetic profiles. This approach significantly improves drug efficacy and reduces adverse reactions, streamlining the path from research and development to market. Pharmaceutical firms are increasingly leveraging genetic data to predict how different populations will respond to medications, optimizing their investment in drug development and marketing strategies. In healthcare, precision medicine is revolutionizing patient care by allowing providers to devise personalized treatment plans. Hospitals and clinics benefit from integrating genetic information into patient records, enhancing diagnostic accuracy and treatment effectiveness. This personalized approach not only improves patient outcomes but also increases operational efficiency by reducing trial-and-error in treatment selection. Healthcare providers can thus offer more targeted, effective care, improving patient satisfaction and loyalty. The biotechnology sector is harnessing precision medicine for advanced diagnostics development. By focusing on genetic markers and individual health profiles, biotech companies are creating diagnostic tools that can detect diseases earlier and with greater precision. These advancements enable healthcare providers to implement preventative measures and treatments more effectively, highlighting the critical role of precision medicine in early diagnosis and intervention. Overall, precision medicine's B2B use cases across pharmaceuticals, healthcare, and biotechnology underline its potential to personalize and enhance treatments, diagnostics, and drug development, reflecting a significant shift towards more individualized, efficient, and effective medical care.
Precision medicine, a rapidly evolving approach that tailors medical treatment to the individual characteristics of each patient, currently sits at various Technology Readiness Levels (TRLs) depending on the specific application or technology in question. Broadly, many precision medicine technologies are between TRL 4 (technology validated in lab) and TRL 7 (system prototype demonstration in operational environment), with some even reaching TRL 9 (actual system proven in operational environment) in areas like genomics and pharmacogenomics. This variance largely stems from the complexity of integrating vast amounts of biological data with patient health information, necessitating sophisticated computational tools for data analysis and interpretation. The higher TRLs in genomics are due to significant advancements in sequencing technologies and bioinformatics that allow for the effective analysis of genetic data to inform treatment plans. However, challenges remain in areas such as data privacy, standardization of data formats, and the integration of precision medicine tools into clinical workflows, which can slow the progression to higher TRLs. Additionally, the need for extensive clinical trials to validate the efficacy of personalized treatments further contributes to the diverse range of TRLs within the field. These technical and operational challenges highlight the dynamic nature of precision medicine's development and its potential to revolutionize healthcare once these hurdles are overcome.
In the Short-Term, precision medicine is poised to make significant strides in integrating big data analytics with patient care. The immediate focus is on enhancing genetic sequencing technologies and the computational platforms that analyze vast datasets. This integration will facilitate more accurate diagnoses and tailored treatment plans, with a notable increase in the use of wearable technology to monitor patient health in real-time, providing data directly to healthcare providers for more informed decision-making. The Mid-Term phase will witness the expansion of precision medicine into mainstream healthcare, driven by advancements in artificial intelligence (AI) and machine learning (ML). These technologies will refine the predictive capabilities of precision medicine, enabling the identification of diseases at their nascent stages and predicting patient responses to various treatments. This period will also see a surge in personalized drug development, leveraging individual genetic information to design highly effective, patient-specific medications with fewer side effects. In the Long-Term, the convergence of biotechnology, nanotechnology, and advanced computing is expected to revolutionize precision medicine. The development of highly sophisticated, minimally invasive diagnostic tools and the ability to manipulate biological systems at the molecular level will usher in a new era of preventive medicine. This will likely include the widespread application of gene editing techniques to correct genetic disorders before they manifest, ultimately leading to a significant reduction in the prevalence of chronic diseases and a substantial extension of human lifespan.
